Common Contracts

AGREEMENT AND PLAN OF MERGER by and among NANTKWEST, INC., NECTARINE MERGER SUB, INC. and IMMUNITYBIO, INC. Dated as of December 21, 2020

Merger Agreement • December 22nd, 2020 • NantKwest, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Merger Agreement
• Filed
  December 22nd, 2020
• Company
  NantKwest, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This AGREEMENT AND PLAN OF MERGER, dated as of December 21, 2020 (this “Agreement”), is entered into by and among ImmunityBio, Inc., a Delaware corporation (the “Company”), NantKwest, Inc., a Delaware corporation (“Parent”), and Nectarine Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub” and, together with the Company and Parent, the “Parties” and each, a “Party”).

AGREEMENT AND PLAN OF MERGER by and among NANTKWEST, INC., NECTARINE MERGER SUB, INC. and IMMUNITYBIO, INC. Dated as of December 21, 2020

Merger Agreement • December 21st, 2020 • Cambridge Equities, LP • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Merger Agreement
• Filed
  December 21st, 2020
• Company
  Cambridge Equities, LP
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This AGREEMENT AND PLAN OF MERGER, dated as of December 21, 2020 (this “Agreement”), is entered into by and among ImmunityBio, Inc., a Delaware corporation (the “Company”), NantKwest, Inc., a Delaware corporation (“Parent”), and Nectarine Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub” and, together with the Company and Parent, the “Parties” and each, a “Party”).

AGREEMENT AND PLAN OF MERGER by and among EIDOS THERAPEUTICS, INC., BRIDGEBIO PHARMA, INC. GLOBE MERGER SUB I, INC. and GLOBE MERGER SUB II, INC. Dated as of October 5, 2020

Merger Agreement • October 6th, 2020 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Merger Agreement
• Filed
  October 6th, 2020
• Company
  BridgeBio Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This AGREEMENT AND PLAN OF MERGER, dated as of October 5, 2020 (this “Agreement”), is entered into by and among Eidos Therapeutics, Inc., a Delaware corporation (the “Company”), BridgeBio Pharma, Inc., a Delaware corporation (“Parent”), Globe Merger Sub I, Inc., a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub”), and Globe Merger Sub II, Inc., a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub II” and, together with the Company, Parent and Merger Sub, the “Parties” and each, a “Party”).

AGREEMENT AND PLAN OF MERGER by and among EIDOS THERAPEUTICS, INC., BRIDGEBIO PHARMA, INC. GLOBE MERGER SUB I, INC. and GLOBE MERGER SUB II, INC. Dated as of October 5, 2020

Merger Agreement • October 5th, 2020 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Merger Agreement
• Filed
  October 5th, 2020
• Company
  BridgeBio Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This AGREEMENT AND PLAN OF MERGER, dated as of October 5, 2020 (this “Agreement”), is entered into by and among Eidos Therapeutics, Inc., a Delaware corporation (the “Company”), BridgeBio Pharma, Inc., a Delaware corporation (“Parent”), Globe Merger Sub I, Inc., a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub”), and Globe Merger Sub II, Inc., a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub II” and, together with the Company, Parent and Merger Sub, the “Parties” and each, a “Party”).